Humana (NYSE:HUM) traded ~7% higher in the premarket on Wednesday after the managed care firm, with its Q2 2025 results, ...

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

Key Takeaways Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana Inc. (NYSE: HUM) touted “solid” second-quarter results and emphasized a multi-year transformation centered on scalable growth, cost reduction and ...

The company updated full-year revenue expectations to at least $128 billion, a $2 billion increase over its prior projection.

Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher ...

CenterWell Home Health: CenterWell Home Health is one of the nation’s largest providers of in-home health care with more than 350 locations across 38 states, more than 9,000 clinicians, and over ...